Vitamin D and Non-coding RNAs: New Insights into the Regulation of Breast Cancer

Author:

Shahrzad Mohammad Karim1,Gharehgozlou Reyhaneh2,Fadaei Sara3,Hajian Parastoo2,Mirzaei Hamid Reza2

Affiliation:

1. Department of Internal Medicine and endocrinology, Shohadae Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran,Iran

2. Cancer Research Center, Shohada Tajrish Hospital, Department of Radiation Oncology, Shahid Beheshti University of Medical Sciences, Tehran,Iran

3. Department of Internal Medicine and endocrinology, Beheshti University of Medical Sciences, Tehran,Iran

Abstract

Breast cancer, a life-threatening serious disease with a high incident rate among women, is responsible for thousands of cancer-associated death worldwide. Numerous investigations have evaluated the possible mechanisms related to this malignancy. Among them, non-coding RNAs (ncRNAs), i.e., microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs have recently attracted attention of researchers. In addition to recent studies for evaluating the role of ncRNAs in breast cancer etiology, some investigations have revealed that vitamin D has regulatory and therapeutic roles in breast cancer. Moreover, an important link between vitamin D and ncRNAs in cancer therapy has been highlighted. Herein, the aim of this study was to discuss the available data on the mentioned link in breast cancer.

Publisher

Bentham Science Publishers Ltd.

Subject

Molecular Biology,Molecular Medicine,General Medicine,Biochemistry

Reference200 articles.

1. Estebanez N; Gomez-Acebo I.; Vitamin D exposure and Risk of Breast Cancer: a meta-analysis 2018,8(1),9039

2. Jafari SH; Saadatpour Z; Salmaninejad A; Momeni F; Mokhtari M; Nahand JS; Breast cancer diagnosis: Imaging techniques and biochemical markers 2018,233(7),5200-5213

3. Fitzmaurice C.; Abate D.; Abbasi N.; Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol Global Burden of Disease Cancer Collaboration2019

4. Mirzaei H.R.; Sahebkar A.; Salehi R.; Boron neutron capture therapy: Moving toward targeted cancer therapy. J Cancer Res Ther 2016,12(2),520-525

5. Vakili-Ghartavol R; Mombeiny R; Salmaninejad A; Tumor-associated macrophages and epithelial-mesenchymal transition in cancer: Nanotechnology comes into view 2018,233(12),9223-9236

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3